One of the most common mutations in GBM, the deletion of exons 2–7 of the EGFR gene, called EGFRvIII, has been shown to activate Stat3 and Stat5 transcriptional pathways contributing to cell cycle progression and preventing apoptosis of glioma cells [49]. This evidence concerns the gene STAT3 and glioma.